149 related articles for article (PubMed ID: 18485044)
1. Patterns of intervention for renal lesions in von Hippel-Lindau disease.
Matin SF; Ahrar K; Wood CG; Daniels M; Jonasch E
BJU Int; 2008 Sep; 102(8):940-5. PubMed ID: 18485044
[TBL] [Abstract][Full Text] [Related]
2. Nephron sparing surgery in von Hippel-Lindau associated renal cell carcinoma; clinicopathological long-term follow-up.
Jilg CA; Neumann HP; Gläsker S; Schäfer O; Leiber C; Ardelt PU; Schwardt M; Schultze-Seemann W
Fam Cancer; 2012 Sep; 11(3):387-94. PubMed ID: 22426863
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of von Hippel-Lindau disease with renal involvement].
Chrétien Y; Chauveau D; Richard S; Droz D; Correas JM; Mejean A; Dufour B; Grünfeld JP
Prog Urol; 1997 Dec; 7(6):939-47. PubMed ID: 9490138
[TBL] [Abstract][Full Text] [Related]
4. [Renal cell carcinoma in von Hippel-Lindau disease. Nephron sparing surgery.].
Urbieta Anza A; Llarena Ibarguren R; Tomás Zabala Egurrola JA; Gutierrez Zurimendi G; Iturregui Del Pozo AM; Arruza Echevarria A
Arch Esp Urol; 2018 Nov; 71(9):757-764. PubMed ID: 30403378
[TBL] [Abstract][Full Text] [Related]
5. Repeat Percutaneous Radiofrequency Ablation of T1 Renal Cell Carcinomas is Safe in Patients with Von Hippel-Lindau Disease.
Wessendorf J; König A; Heers H; Mahnken AH
Cardiovasc Intervent Radiol; 2021 Dec; 44(12):2022-2025. PubMed ID: 34414496
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease: indications, techniques, complications, and outcomes.
Park BK; Kim CK; Park SY; Shen SH
Acta Radiol; 2013 May; 54(4):418-27. PubMed ID: 23446745
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease previously undergoing a radical nephrectomy or repeated nephron-sparing surgery.
Park SY; Park BK; Kim CK; Lee HM; Jeon SS; Seo SI; Jeong BC; Choi HY
Acta Radiol; 2011 Jul; 52(6):680-5. PubMed ID: 21525107
[TBL] [Abstract][Full Text] [Related]
8. von Hippel-Lindau disease with bilateral multiple renal cell carcinoma managed by right radical nephrectomy and left repeat partial nephrectomy.
Ansari MS; Gupta NP; Kumar P
Int Urol Nephrol; 2003; 35(4):471-3. PubMed ID: 15198146
[TBL] [Abstract][Full Text] [Related]
9. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
Blute ML; Amling CL; Bryant SC; Zincke H
Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous ultrasound-guided radiofrequency ablation treatment and genetic testing for renal cell carcinoma with Von Hippel-Lindau disease.
Gao Y; Xu M; Xu ZF; Liu DW; Tu XA; Zheng YL; Wang DH; Sun XZ; Zheng FF; Qiu SP; Lü MD; Zhang YY; Xie XY; Deng CH
J Xray Sci Technol; 2012; 20(1):121-9. PubMed ID: 22398592
[TBL] [Abstract][Full Text] [Related]
11. Nephron-sparing surgery across a nation - outcomes from the British Association of Urological Surgeons 2012 national partial nephrectomy audit.
Fernando A; Fowler S; O'Brien T;
BJU Int; 2016 Jun; 117(6):874-82. PubMed ID: 26469291
[TBL] [Abstract][Full Text] [Related]
12. Management of renal cell carcinoma in von Hippel-Lindau disease.
Hes FJ; Slootweg PJ; van Vroonhoven TJ; Hené RJ; Feldberg MA; Zewald RA; Ploos van Amstel JK; Höppener JW; Pearson PL; Lips CJ
Eur J Clin Invest; 1999 Jan; 29(1):68-75. PubMed ID: 10092992
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous Radiofrequency Ablation Versus Robotic-Assisted Partial Nephrectomy for the Treatment of Small Renal Cell Carcinoma.
Pantelidou M; Challacombe B; McGrath A; Brown M; Ilyas S; Katsanos K; Adam A
Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1595-1603. PubMed ID: 27435582
[TBL] [Abstract][Full Text] [Related]
14. Probe ablation as salvage therapy for renal tumors in von Hippel-Lindau patients: the Cleveland Clinic experience with 3 years follow-up.
Yang B; Autorino R; Remer EM; Laydner HK; Hillyer S; Altunrende F; White MA; Khanna R; Stein RJ; Haber GP; O'Malley CM; Kaouk JH
Urol Oncol; 2013 Jul; 31(5):686-92. PubMed ID: 21723752
[TBL] [Abstract][Full Text] [Related]
15. Progress in nephron sparing therapy for renal cell carcinoma and von Hippel-Lindau disease.
Joly D; Méjean A; Corréas JM; Timsit MO; Verkarre V; Deveaux S; Landais P; Grünfeld JP; Richard S
J Urol; 2011 Jun; 185(6):2056-60. PubMed ID: 21496837
[TBL] [Abstract][Full Text] [Related]
16. Natural history of renal tumours in von Hippel-Lindau disease: a large retrospective study of Chinese patients.
Peng X; Chen J; Wang J; Peng S; Liu S; Ma K; Zhou J; Hong B; Zhou B; Zhang J; Cai L; Gong K
J Med Genet; 2019 Jun; 56(6):380-387. PubMed ID: 30745424
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous microwave ablation on management of hereditary renal cell carcinoma in Von Hippel-Lindau disease.
Chen J; Zheng L; Zhang W; Wang Z; Yu J; Liang P
Int J Hyperthermia; 2024; 41(1):2308079. PubMed ID: 38346873
[TBL] [Abstract][Full Text] [Related]
18. Multimodal image-guided ablation on management of renal cancer in Von-Hippel-Lindau syndrome patients from 2004 to 2021 at a specialist centre: A longitudinal observational study.
Chan VW; Lenton J; Smith J; Jagdev S; Ralph C; Vasudev N; Bhattarai S; Lewington A; Kimuli M; Cartledge J; Wah TM
Eur J Surg Oncol; 2022 Mar; 48(3):672-679. PubMed ID: 34728141
[TBL] [Abstract][Full Text] [Related]
19. First-Line sunitinib in patients with renal cell carcinoma (RCC) in von Hippel-Lindau (VHL) disease: clinical outcome and patterns of radiological response.
Roma A; Maruzzo M; Basso U; Brunello A; Zamarchi R; Bezzon E; Pomerri F; Zovato S; Opocher G; Zagonel V
Fam Cancer; 2015 Jun; 14(2):309-16. PubMed ID: 25391617
[TBL] [Abstract][Full Text] [Related]
20. Renal lesions in Von Hippel-Lindau disease: the benign, the malignant, the unknown.
Salomé F; Colombeau P; Fermeaux V; Cazaux P; Dumas JP; Pfeifer P; Moreau JJ; Richard S; Labrousse F
Eur Urol; 1998; 34(5):383-92. PubMed ID: 9803000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
